MP47-09 THE ADDED VALUE OF HISTOLOGICAL SUBTYPE IN THE PREDICTION OF ONCOLOGIC OUTCOMES IN PATIENTS WITH NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA. (May 2022)